Medical cannabis legalisation linked to reduction in opioid use among cancer patients – study

Medical cannabis legalisation linked to reduction in opioid use among cancer patients – study
Cannabis Health News

Cancer patients used less opioids to manage their pain while receiving treatment in states where medical cannabis was legalised, according to a new study. The findings of the study suggest that medical cannabis legalisation was associated with a lower rate of opioid dispensing and pain-related hospital admissions among some adults receiving treatment for cancer.  The nature of these associations and their implications for patient safety and quality of life need to be further investigated, say the authors of the paper.  Researchers set out to analyse the link between recent medical cannabis legalisation in the US and changes in opioid-related and pain-related outcomes for adults with newly-diagnosed cancer. The prevalence of pain among this population is thought to be as high as 55% during anticancer treatment. How did the study work? The cross-sectional study examined over 38,000 privately insured patients aged 18 -64 years with a new diagnosis of breast, colorectal, or lung cancer between 2012- 2017, who received cancer treatment during the first six months after diagnosis. They used commercial claims data to estimate the prevalence of opioid use among patients living in 34 states without medical cannabis legalisation by 1 January, 2012.  Secondary analysis then differentiated between medical cannabis legalisation, with and without legal allowances for retail dispensaries.  Findings were measured by the rate of patients who had ‘one or more days of opioids’ and ‘one or more pain-related emergency department visits or hospitalisations’ during the six months after a new cancer diagnosis. Reduction in opioid dispensing The results showed that medical cannabis legalisation was associated with a 5.5% to 19.2% relative reduction in the rate of opioid dispensing. It was also linked to a reduction in the rate of one or more pain-related hospital events from 19.3% to 13.0% among patients with lung cancer who had been prescribed…

Excerpt only …
READ MORE BELOW
Source : Medical cannabis legalisation linked to reduction in opioid use among cancer patients – study

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.